Date Filed | Type | Description |
10/10/2023 |
8-K
| Quarterly results |
08/09/2023 |
8-K
| Quarterly results |
08/09/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
07/31/2023 |
8-K
| Quarterly results |
07/10/2023 |
SC 13G/A
| STATE STREET CORP reports a 0.3% stake in EXIT FILING INOVIO PHARMACEUTICALS INC |
07/07/2023 |
SC 13G/A
| BlackRock Inc. reports a 2.3% stake in INOVIO PHARMACEUTICALS INC |
07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/18/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
05/18/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
05/18/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
05/17/2023 |
4
| Sumner Michael John (Chief Medical Officer) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.
Txns:
| Granted 85,878 restricted stock units
@ $0 |
|
05/17/2023 |
4
| Humeau Laurent (Chief Scientific Officer) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.
Txns:
| Granted 171,756 restricted stock units
@ $0 |
|
05/17/2023 |
4
| KIES PETER (CFO) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.
Txns:
| Granted 171,756 restricted stock units
@ $0 |
|
05/17/2023 |
4
| Shea Jacqueline Elizabeth (CEO) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.
Txns:
| Granted 638,800 restricted stock units
@ $0 |
|
05/16/2023 |
4
| Zoth Lota S. (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.
Txns:
| Exercised 19,000 restricted stock units
@ $0 Granted 35,000 options
@ $0.77, valued at
$27k
Granted 26,000 restricted stock units
@ $0 |
|
05/16/2023 |
4
| YARNO WENDY L (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.
Txns:
| Exercised 19,000 restricted stock units
@ $0 Granted 35,000 options
@ $0.77, valued at
$27k
Granted 26,000 restricted stock units
@ $0 |
|
05/16/2023 |
4
| Weiner David B. (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.
Txns:
| Exercised 19,000 restricted stock units
@ $0 Granted 35,000 options
@ $0.77, valued at
$27k
Granted 26,000 restricted stock units
@ $0 |
|
05/16/2023 |
4
| Shepard Jay (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.
Txns:
| Exercised 19,000 restricted stock units
@ $0 Granted 35,000 options
@ $0.77, valued at
$27k
Granted 26,000 restricted stock units
@ $0 |
|
05/16/2023 |
4
| BENITO SIMON X (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.
Txns:
| Exercised 19,000 restricted stock units
@ $0 Granted 35,000 options
@ $0.77, valued at
$27k
Granted 26,000 restricted stock units
@ $0 |
|
05/16/2023 |
4
| Miller Ann Calby (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.
Txns:
| Exercised 19,000 restricted stock units
@ $0 Granted 35,000 options
@ $0.77, valued at
$27k
Granted 26,000 restricted stock units
@ $0 |
|
05/16/2023 |
4
| DANSEY ROGER D (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.
Txns:
| Exercised 12,000 restricted stock units
@ $0 Granted 35,000 options
@ $0.77, valued at
$27k
Granted 26,000 restricted stock units
@ $0 Exercised 19,000 restricted stock units
@ $0 |
|
05/12/2023 |
4
| Shea Jacqueline Elizabeth (CEO) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.
Txns:
| Paid exercise price by delivering 28,704 shares
@ $0.81, valued at
$23.3k
Exercised 66,000 restricted stock units
@ $0 |
|
05/10/2023 |
8-K
| Quarterly results |
04/04/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
03/31/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
03/28/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
03/28/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
03/28/2023 |
POS EX
| Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]: |
03/13/2023 |
4
| Weiner David B. (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.
Txns:
| Sold 5,833 shares
@ $1.15, valued at
$6.7k
Exercised 11,666 restricted stock units
@ $0 |
|
03/13/2023 |
4
| Humeau Laurent (Chief Scientific Officer) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.
Txns:
| Paid exercise price by delivering 20,658 shares
@ $1.13, valued at
$23.3k
Exercised 59,737 restricted stock units
@ $0 |
|
03/13/2023 |
4
| Shea Jacqueline Elizabeth (CEO) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.
Txns:
| Paid exercise price by delivering 25,980 shares
@ $1.13, valued at
$29.4k
Exercised 59,737 restricted stock units
@ $0 |
|
03/13/2023 |
4
| KIES PETER (CFO) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.
Txns:
| Paid exercise price by delivering 31,410 shares
@ $1.13, valued at
$35.5k
Exercised 59,737 restricted stock units
@ $0 |
|
03/01/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
03/01/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
|